Pulmonary Valve Replacement in Tetralogy of Fallot

• Published in: JACC. Cardiovascular interventions 2024-01, Vol.17 (2), p.217-227
• Main Authors: Gröning, Mathis, Smerup, Morten Holdgaard, Munk, Kim, Andersen, Helle, Nielsen, Dorte Guldbrand, Nissen, Henrik, Mortensen, Ulrik Markus, Jensen, Annette Schophuus, Bække, Pernille Steen, Bjerre, Jesper, Engholm, Morten, Vejlstrup, Niels, Juul, Klaus, Søndergaard, Eva Vad, Thyregod, Hans Gustav Hørsted, Andersen, Henrik Ørbæk, Helvind, Morten, De Backer, Ole, Jøns, Christian, Schmidt, Michael Rahbek, Jørgensen, Troels Højsgaard, Sondergaard, Lars
• Format: Article
• Language: English
• Subjects: bioprosthetic pulmonary valves; durability; procedural volume; pulmonary valve replacement; tetralogy of Fallot
• ISSN: 1936-8798
• DOI: 10.1016/j.jcin.2023.10.070

Robust data on changes in pulmonary valve replacement (PVR) procedural volume and predictors of bioprosthetic pulmonary valve (BPV) durability in patients with tetralogy of Fallot (TOF) are scarce. This study sought to assess temporal trends in PVR procedural volume and BPV durability in a nationwide, retrospective TOF cohort. Data were obtained from patient records. Robust linear regression was used to assess temporal trends in PVR procedural volume. Piecewise exponential additive mixed models were used to estimate BPV durability, defined as the time from implantation to redo PVR with death as a competing risk, and to assess risk factors for reduced durability. In total, 546 PVR were performed in 384 patients from 1976 to 2021. The annual number of PVR increased from 0.4 to 6.0 per million population (P < 0.001). In the last decade, the transcatheter PVR volume increased by 20% annually (P < 0.001), whereas the surgical PVR volume did not change significantly. The median BPV durability was 17 years (Q1: 10-Q3: 10 years-not applicable). There was no significant difference in the durability of different BPV after adjustment for confounders. Age at PVR (HR: 0.78 per 10 years from